查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2125099

全球連續血糖監測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Continuous Blood Glucose Monitoring Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 203 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球連續血糖監測市場預計將從2025年的167.3億美元成長至2034年的603.9億美元，並預計在2026年至2034年間以15.33%的複合年成長率成長。這項市場擴張的驅動力在於使用者對能夠提供頻繁血糖值資訊而無需完全依賴傳統間歇性檢測的技術的需求日益成長。連續血糖監測系統利用感測器和相關軟體提供血糖值趨勢的連續訊息，幫助使用者和醫療專業人員更深入地了解血糖隨時間的變化。國際糖尿病聯盟（IDF）指出，糖尿病仍是全球面臨的重大健康挑戰，亟需改善血糖管理工具。人們對糖尿病管理的認知不斷提高以及穿戴式監測技術的進步，進一步推動了對連續血糖監測解決方案的興趣。

持續血糖監測市場的發展主要得益於感測器精度、配戴舒適度、連接性和數據分析能力的提升。現代系統能夠將血糖值資訊傳輸至智慧型手機和其他連網設備，使用戶能夠追蹤血糖趨勢並接收警報。與數位健康平台的整合也為遠端監測和更個人化的護理創造了機會。製造商正致力於縮小感測器尺寸、提升易用性並增強長期使用的便利性。報銷政策、價格承受能力、臨床接受度以及醫療服務的可近性仍然是影響各國及不同患者群體採用率的關鍵因素。

微創監測和連線健診醫療領域的持續創新是未來發展的基礎。與胰島素輸注系統和數位治療平台的整合可望進一步提升連續血糖資訊的效用。感測器耐用性、準確性、可負擔性和自動化數據分析的進步，有望推動其在現有用戶群之外的更廣泛應用。隨著醫療基礎設施和公眾意識的提升，新興市場蘊藏著巨大的機會。隨著血糖監測日益互聯化和數據驅動化，那些將可靠的感測技術與直覺的軟體、安全的數據管理和合理的價格相結合的製造商，有望鞏固其市場地位。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節提供清晰的市場概覽，包括關鍵定義、分類和當前產業趨勢。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的客製化服務，可根據您的具體需求自訂報告。這包括額外的細分、特定國家/地區的分析、競爭對手分析、客製化資料點或專注於特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球連續血糖監測市場：依組件分類

  • 市場分析、洞察與預測
  • 感應器
  • 發送器
  • 接收器

第5章 全球連續血糖監測市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院和診所
  • 首頁 / 個人版
  • 成人
  • 兒童

第6章 全球連續血糖監測市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • A. Menarini Diagnostics Srl
    • Abbott Laboratories
    • Afon Technology Ltd
    • AgaMatrixInc
    • Ascensia Diabetes Care Holdings AG
    • Bilinq Incorporated（Biolinq Incorporated）
    • DexComInc
    • F. Hoffmann-La Roche Ltd
    • GlucoRx Limited
    • GlucotrackInc
    • HAGAR Hf
    • I-SENSInc
    • Integrity Applications Inc
    • Know LabsInc
    • LifeScanInc
    • Medtronic Plc
    • Medtrum Technologies Inc
    • MicroTech Medical（Hangzhou）Co.Ltd
    • Nemaura Medical Inc
    • Senseonics HoldingsInc
    • Sinocare Inc
    • Terumo Corporation
    • Ypsomed Holding AG
    • Zhejiang POCTech Co.Ltd
簡介目錄
Product Code: VMR112115553

The global continuous blood glucose monitoring market size is expected to reach USD 60.39 Billion in 2034 from USD 16.73 Billion in 2025, growing at a CAGR of 15.33% during 2026-2034.This market is growing as demand increases for technologies that provide frequent glucose information without requiring users to rely exclusively on conventional intermittent testing. Continuous glucose monitoring systems use sensors and associated software to provide ongoing information about glucose patterns, helping users and healthcare professionals better understand changes over time. According to the International Diabetes Federation, diabetes continues to represent a substantial global health challenge, supporting the need for improved glucose-management tools. Expanding awareness of diabetes management and technological improvements in wearable monitoring are encouraging wider interest in continuous glucose monitoring solutions.

The continuous blood glucose monitoring market is being influenced by improvements in sensor accuracy, wearability, connectivity, and data interpretation. Modern systems can transmit glucose information to smartphones and other connected devices, enabling users to review trends and receive alerts. Integration with digital health platforms is also creating opportunities for remote monitoring and more personalized care. Manufacturers are working to make sensors smaller, easier to apply, and more convenient for extended use. Reimbursement policies, affordability, clinical acceptance, and access to healthcare remain important factors influencing adoption across different countries and patient populations.

Future prospects are supported by continued innovation in minimally invasive monitoring and connected healthcare. Integration with insulin-delivery systems and digital therapeutic platforms could further increase the usefulness of continuous glucose information. Advances in sensor longevity, accuracy, affordability, and automated data analysis may broaden adoption beyond current user groups. Emerging markets could provide significant opportunities as healthcare infrastructure and awareness improve. Manufacturers that combine reliable sensing technology with intuitive software, secure data management, and accessible pricing are likely to strengthen their market positions as glucose monitoring becomes increasingly connected and data-driven.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Component

  • Sensors
  • Transmitters
  • Receivers

By End User

  • Hospitals/Clinics
  • Home/Personal

By Demography

  • Adult
  • Pediatric

COMPANIES PROFILED

  • A. Menarini Diagnostics S.r.l., Abbott Laboratories, Afon Technology Ltd., AgaMatrix, Inc., Ascensia Diabetes Care Holdings AG, Bilinq Incorporated (Biolinq Incorporated), DexCom, Inc., F. Hoffmann-La Roche Ltd., GlucoRx Limited, Glucotrack, Inc., HAGAR hf., i-SENS, Inc., Integrity Applications Inc., Know Labs, Inc., LifeScan, Inc., Medtronic plc, Medtrum Technologies Inc., MicroTech Medical (Hangzhou) Co., Ltd., Nemaura Medical Inc., Senseonics Holdings, Inc., Sinocare Inc., Terumo Corporation, Ypsomed Holding AG, Zhejiang POCTech Co., Ltd.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET: BY COMPONENT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Component
  • 4.2. Sensors Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Transmitters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Receivers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals/Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Home/Personal Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. By Demography Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Adult Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Pediatric Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING MARKET: BY REGION 2022-2034 (USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Component
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Component
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Component
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Component
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Component
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CONTINUOUS BLOOD GLUCOSE MONITORING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 A. Menarini Diagnostics S.r.l
    • 8.2.2 Abbott Laboratories
    • 8.2.3 Afon Technology Ltd
    • 8.2.4 AgaMatrixInc
    • 8.2.5 Ascensia Diabetes Care Holdings AG
    • 8.2.6 Bilinq Incorporated (Biolinq Incorporated)
    • 8.2.7 DexComInc
    • 8.2.8 F. Hoffmann-La Roche Ltd
    • 8.2.9 GlucoRx Limited
    • 8.2.10 GlucotrackInc
    • 8.2.11 HAGAR Hf
    • 8.2.12 I-SENSInc
    • 8.2.13 Integrity Applications Inc
    • 8.2.14 Know LabsInc
    • 8.2.15 LifeScanInc
    • 8.2.16 Medtronic Plc
    • 8.2.17 Medtrum Technologies Inc
    • 8.2.18 MicroTech Medical (Hangzhou) Co.Ltd
    • 8.2.19 Nemaura Medical Inc
    • 8.2.20 Senseonics HoldingsInc
    • 8.2.21 Sinocare Inc
    • 8.2.22 Terumo Corporation
    • 8.2.23 Ypsomed Holding AG
    • 8.2.24 Zhejiang POCTech Co.Ltd